AETHLON MEDICAL INC
PublicHealthcare · San Diego, CA
Financials
FY2011–FY2026 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 8 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Cap table
Share counts as of Jan 30, 2025| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Class A Warrants | 7,800,000 | — | 59.9% | — |
| Class B Warrants | 5,220,000 | — | 40.0% | — |
| Common Stock | 12,459 | — | 0.1% | — |
| Total | 13,032,459 | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Chetan S. Shah, M.D.41 (0.13%) Aug 2024 → 66 (0.2%) Dec 2024 → 78 (0.24%) Jan 2025
- Guy F. Cipriani45 (0.14%) Aug 2024 → 48 (0.15%) Dec 2024 → 4 (0.01%) Jan 2025
- Edward G. Broenniman0 Jul 2014 → 48 (0.15%) Aug 2024 → 81 (0.25%) Dec 2024 → 98 (0.3%) Jan 2025
- James B. Frakes0 Jul 2014 → 56 (0.17%) Aug 2024 → 61 (0.19%) Dec 2024 → 55 (0.17%) Jan 2025
- Nicolas Gikakis42 (0.13%) Aug 2024 → 66 (0.2%) Dec 2024 → 79 (0.24%) Jan 2025
- Angela Rossetti62 (0.19%) Aug 2024 → 104 (0.32%) Dec 2024 → 124 (0.38%) Jan 2025
- Steven P. LaRosa, M.D.40 (0.12%) Aug 2024 → 47 (0.14%) Dec 2024 → 51 (0.16%) Jan 2025
Principal holders% as the filing states it, Jan 30, 2025
- Angela Rossetti49,660 common stock—of company
- Charles J. Fisher, Jr., M.D.1,957 common stock—of company
- Chetan S. Shah, M.D.31,375 common stock—of company
- Edward G. Broenniman39,070 common stock—of company
- Guy F. Cipriani1,791 common stock—of company
- James B. Frakes22,011 common stock—of company
- Nicolas Gikakis31,462 common stock—of company
- Steven P. LaRosa, M.D.20,317 common stock—of company
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
6 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 105 filings on EDGAR- Form 10-QAug 13, 20260001683168-26-006347EDGAR
- Form 10-KJun 10, 20260001683168-26-004710EDGAR
- Form 10-QFeb 12, 20260001683168-26-000964EDGAR
- Form DDec 23, 20250000882291-25-000004EDGAR
- Form 10-QNov 12, 20250001683168-25-008271EDGAR
- Form 1-A-WAug 20, 20250001683168-25-006350EDGAR
- Form 10-QAug 13, 20250001683168-25-006049EDGAR
- Form 10-KJun 26, 20250001683168-25-004780EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.